Dendritic Cell-Derived Exosomes may be a Tool for Cancer Immunotherapy by Converting Tumor Cells into Immunogenic Targets

Dendritic cells (DCs) have been attracting attention in cancer immunotherapy because of their role in inducing and modulating effective immune responses. Besides the direct contact with other cell types and the secretion of cytokines, it is becoming clear that nanovesicles, such as exosomes (Exo), s...

Descripción completa

Detalles Bibliográficos
Autores principales: Romagnoli, Graziela Gorete, Zelante, Bruna Barbosa, Toniolo, Patrícia Argenta, Migliori, Isabella Katz, Barbuto, José Alexandre M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298225/
https://www.ncbi.nlm.nih.gov/pubmed/25646096
http://dx.doi.org/10.3389/fimmu.2014.00692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298225/
https://www.ncbi.nlm.nih.gov/pubmed/25646096
http://dx.doi.org/10.3389/fimmu.2014.00692

Ejemplares similares